Leveraging combined expertise. Value through evidence.
What is DHT.health?
DHT.health is led by Sam Bristow and George Morgan. Having worked together in previous companies focusing on Health Economic, Real-World Evidence and Digital Health.
Their mission is to identify and support unmet healthcare research needs by bringing together key stakeholders.
DHT.health will deliver combined expertise to provide a comprehensive service focusing on industry standard real-world evidence, preference research, health economics and outcomes research with integrated digital development, ethics, compliance and data governance support. Providing valuable evidence and development solutions to support the Life Science and Digital Health Industry alongside supporting the needs of Patient Organisations.
Sam Bristow, CEO
Sam has experience conducting primary real-world evidence and lived experience research. He has led the implementation of various digital solutions into HEOR, RWE and preference research including creating a digital health multi-device-based research application where those affected by a rare disease can contribute to research. Academically trained in economics and risk management he has real-world expertise in digital development, ethics, compliance and data governance.
George Morgan, Director of Research
George is an experienced health economics, preference research and outcomes researcher with a motivation to empower the stakeholder voice and deliver valuable evidence to support novel treatments and products. Academically trained in economics and health economics at Lancaster University and the University of York respectively, prior to his roles in the consultancy environment supporting life science companies over the last 7 years. He has extensive experience leading and executing impactful HEOR projects, within haematology, hepatology, oncology, dermatology and musculoskeletal diseases. This is further highlighted by his proven track record in evidence dissemination which can be accessed here.
Commentaires